AnaptysBio
ANAB
$26.34
Share price
1.23%
Change (1 day)
25.61%
Change (1 year)
Categories
AnaptysBio (ANAB) - Cash on Hand
Cash on Hand as of December 2023 : $0.39 B
According to AnaptysBio's latest financial reports the company has $0.39 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
AnaptysBio - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.39 B | -11.41% |
| 2022-12-31 | $0.44 B | -19.5% |
| 2021-12-31 | $0.54 B | 39.23% |
| 2020-12-31 | $0.39 B | 5.19% |
| 2019-12-31 | $0.37 B | -12.38% |
| 2018-12-31 | $0.42 B | 71.93% |
| 2017-12-31 | $0.24 B | 384.87% |
| 2016-12-31 | $51.23 M | -0.87% |
| 2015-12-31 | $51.68 M | 132.94% |
| 2014-12-31 | $22.18 M | 689.61% |
| 2013-12-31 | $2.81 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -46.74% | 🇺🇸 USA |